Experience
LIAO Meiqi, ZHUANG Jiafang, OUYANG Shandan, CAI Yanru
Objective: To compare the effects of Enoxaparin Sodium and Dalteparin Sodium on coagulation function, dialysis adequacy and inflammatory indexes in hemodialysis patients. Method: A total of 160 patients who underwent hemodialysis in the 73rd Group Military Hospital of the Chinese People's Liberation Army from July 2019 to August 2021 were selected and randomly divided into observation group and control group, with 80 cases in each group. The observation group received dialysis treatment with Enoxaparin Sodium, and the control group received dialysis treatment with Dalteparin Sodium. The coagulation indexes [activated clotting time of whole blood (ACT), prothrombin time (PT), fibrinogen (FIB), activated partial thrombin time (APTT) and D-dimer], inflammation indexes [tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), procalcitonin (PCT), C-reactive protein (CRP), neutrophil to lymphocyte ratio (NRL)] of the two groups were compared before dialysis and after a single dialysis; the levels of hemoglobin (Hb), platelet (PLT), albumin (ALB), calcium (Ca2+), phosphorus (P3+), urea clearance index (Kt/V), urea reduction ratio (URR), blood urea nitrogen (BUN) and serum creatinine (Scr) were compared between the two groups after a single dialysis and 3 months after dialysis; the clinical effects of the two groups were compared. Result: Before dialysis, there were no statistically significant differences between the two groups in coagulation indexes such as ACT, PT, FIB, APPT and D-dimer (P>0.05); after a single dialysis, the above coagulation indexes in the observation group were better than those in the control group, and the differences were statistically significant (P<0.05). After a single dialysis, there were no statistically significant differences in the Hb, PLT, ALB, Ca2+, P3+, BUN, Scr, Kt/V and URR indexes of the two groups (P>0.05). After 3 months of dialysis, the levels of Hb, ALB, Kt/V and URR in the observation group were higher than those in the control group, and the indicators of PLT, P3+, BUN and Scr in the observation group were lower than those in the control group, the differences were statistically significant (P<0.05). After a single dialysis, the levels of TNF-α, IL-6, PCT, CRP and NRL of observation group were significantly lower than those of the control group, the differences were statistically significant (P<0.05). The effective rate of treatment in the observation group was significantly higher than that in the control group, the difference was statistically significant (P<0.05). Conclusion: The use of Enoxaparin Sodium in hemodialysis patients with coagulation function, dialysis adequacy and inflammation has an obvious improvement effect.